Figure 3
From: Ikaros expression is associated with an increased risk of chronic graft-versus-host disease
Relative expression of Ikaros in the patients’ peripheral blood samples 21 days after engraftment in patients with (yes) or without (no) moderate/severe cGVHD diagnosis.
